Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT06976632
Eligibility Criteria:
Inclusion Criteria: Pregnant women who meet the following criteria will be included in the study:
* Over the age of 18,
* Scheduled to receive a tetanus vaccine,
* Able to speak and communicate in Turkish,
* Willing to participate in the study,
* Not experiencing any pain for any reason prior to the injection.
Exclusion Criteria: Pregnant women who meet any of the following criteria will be excluded from the study:
* Under the age of 18,
* Received a tetanus vaccine for reasons other than pregnancy,
* Received a vaccine other than tetanus,
* Experiencing pain for any reason prior to the vaccine,
* Have circulatory disorders or peripheral vascular disease,
* Have bleeding or clotting disorders,
* Have a local infection,
* Used painkillers at least 6 hours prior to the procedure,
* Underwent a painful procedure within the last hour,
* Have cold sensitivity,
* Have cognitive or psychological issues.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
42 Years
Study:
NCT06976632
Study Brief:
Protocol Section:
NCT06976632